跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Uriflo-D - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Uriflo-D
Approved
STANDARD
Uriflo-D
Ravenbhel Healthcare Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
33fdb8f9065b7071
Company
Ravenbhel Healthcare Private Limited
Type
Standard
Approval Details
Approval Id
33fdb8f9065b7071
Drug Approval Philippines Name
Uriflo-D
Product Name
Uriflo-D
Registration Number
DRP-12159
Brand Name
Uriflo-D
Generic Name
Dutasteride + Tamsulosin Hydrochloride
Dosage Form
Capsule
Dosage Strength
500 mcg/400 mcg
Manufacturer
Ravenbhel Healthcare Private Limited
Importer
Khriz Pharma Trading Inc.
Distributor
Khriz Pharma Trading Inc.
Issuance Date
24 June 2022
Expiry Date
24 June 2027
Pharmacologic Category
Drugs Used in Benign Prostatic Hypertrophy (Alpha-adrenoreceptor antagonist)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
33fdb8f9065b7071
Type
Standard
Back to Philippines FDA Approvals